BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 784737 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C44H46N8O6/c1-6-31-25-32(42(53)45-19-20-56-23-24-57-22-21-55-5)27-33(26-31)47-43-46-18-17-41(50-43)58-39-16-15-37(35-9-7-8-10-36(35)39)48-44(54)49-40-28-38(29(2)3)51-52(40)34-13-11-30(4)12-14-34/h1,7-18,25-29H,19-24H2,2-5H3,(H,45,53)(H,46,47,50)(H2,48,49,54) DANMJMQROKKATM-UHFFFAOYSA-N 392690 3-Ethynyl-5-((4-((4-(3-(3-isopropyl-1-(p-tolyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-N-(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-benzamide::US10301288, Example 1::US10301288, Example 2 Mitogen-activated protein kinase 14 Homo sapiens 25.0 US Patent 10.7270/Q24B33N6 aid1798901 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392690&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 86304173 404961017 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 784738 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C44H46N8O6/c1-6-31-25-32(42(53)45-19-20-56-23-24-57-22-21-55-5)27-33(26-31)47-43-46-18-17-41(50-43)58-39-16-15-37(35-9-7-8-10-36(35)39)48-44(54)49-40-28-38(29(2)3)51-52(40)34-13-11-30(4)12-14-34/h1,7-18,25-29H,19-24H2,2-5H3,(H,45,53)(H,46,47,50)(H2,48,49,54) DANMJMQROKKATM-UHFFFAOYSA-N 392690 3-Ethynyl-5-((4-((4-(3-(3-isopropyl-1-(p-tolyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-N-(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-benzamide::US10301288, Example 1::US10301288, Example 2 Proto-oncogene tyrosine-protein kinase Src Human 30.0 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=13&target=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392690&enzyme=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search 86304173 404961017 1 MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 1FMK,1HCS,1HCT,1O41,1O42,1O43,1O44,1O45,1O46,1O47,1O48,1O49,1O4A,1O4B,1O4C,1O4D,1O4E,1O4F,1O4G,1O4H,1O4I,1O4J,1O4K,1O4L,1O4M,1O4N,1O4O,1O4P,1O4Q,1O4R,1SHA,1SHB,1SHD,1SPR,1SPS,1Y57,1YI6,2BDF,2BDJ,2H8H,2PTK,2SRC,4MXO,4MXX,4OML,4OMO,5OB0,5OB1,6ATE,6E6E,7A34,7A35,7A36,7A37,7A3D,7PVY,7PVZ Proto-oncogene tyrosine-protein kinase Src SRC_HUMAN P12931 E1P5V4 Q76P87 Q86VB9 Q9H5A8 784739 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C44H46N8O6/c1-6-31-25-32(42(53)45-19-20-56-23-24-57-22-21-55-5)27-33(26-31)47-43-46-18-17-41(50-43)58-39-16-15-37(35-9-7-8-10-36(35)39)48-44(54)49-40-28-38(29(2)3)51-52(40)34-13-11-30(4)12-14-34/h1,7-18,25-29H,19-24H2,2-5H3,(H,45,53)(H,46,47,50)(H2,48,49,54) DANMJMQROKKATM-UHFFFAOYSA-N 392690 3-Ethynyl-5-((4-((4-(3-(3-isopropyl-1-(p-tolyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-N-(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-benzamide::US10301288, Example 1::US10301288, Example 2 Tyrosine-protein kinase SYK Homo sapiens 370 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=763&target=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392690&enzyme=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search 86304173 404961017 1 MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 1XBA,1XBB,1XBC,3FQE,3FQH,3FQS,3SRV,3TUB,3TUC,3TUD,3VF8,3VF9,4DFL,4DFN,4F4P,4FL1,4FL2,4FYN,4FYO,4FZ6,4FZ7,4GFG,4I0R,4I0S,4I0T,4PUZ,4PV0,4RSS,4WNM,4XG2,4XG3,4XG4,4XG6,4XG7,4XG8,4XG9,4YJO,4YJP,4YJQ,4YJR,4YJS,4YJT,4YJU,4YJV,5C26,5C27,5GHV,5LMA,5LMB,5T68,5TIU,5TR6,5TT7,5Y5T,5Y5U,6HM6,6HM7,6SSB,6VOV,6ZC0,6ZCP,6ZCQ,6ZCR,6ZCS,6ZCU,6ZCX,6ZCY,7SA7,8BI2 Tyrosine-protein kinase SYK KSYK_HUMAN P43405 784740 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C44H46N8O6/c1-6-31-25-32(42(53)45-19-20-56-23-24-57-22-21-55-5)27-33(26-31)47-43-46-18-17-41(50-43)58-39-16-15-37(35-9-7-8-10-36(35)39)48-44(54)49-40-28-38(29(2)3)51-52(40)34-13-11-30(4)12-14-34/h1,7-18,25-29H,19-24H2,2-5H3,(H,45,53)(H,46,47,50)(H2,48,49,54) DANMJMQROKKATM-UHFFFAOYSA-N 392690 3-Ethynyl-5-((4-((4-(3-(3-isopropyl-1-(p-tolyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-N-(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-benzamide::US10301288, Example 1::US10301288, Example 2 Glycogen synthase kinase-3 alpha Homo sapiens 12773 US Patent 10.7270/Q24B33N6 aid1798903 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392690&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 86304173 404961017 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 784741 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C44H46N8O6/c1-6-31-25-32(42(53)45-19-20-56-23-24-57-22-21-55-5)27-33(26-31)47-43-46-18-17-41(50-43)58-39-16-15-37(35-9-7-8-10-36(35)39)48-44(54)49-40-28-38(29(2)3)51-52(40)34-13-11-30(4)12-14-34/h1,7-18,25-29H,19-24H2,2-5H3,(H,45,53)(H,46,47,50)(H2,48,49,54) DANMJMQROKKATM-UHFFFAOYSA-N 392690 3-Ethynyl-5-((4-((4-(3-(3-isopropyl-1-(p-tolyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-N-(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-benzamide::US10301288, Example 1::US10301288, Example 2 Mitogen-activated protein kinase 14 Homo sapiens 52.0 US Patent 10.7270/Q24B33N6 aid1798901 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392690&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 86304173 404961017 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 784742 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C44H46N8O6/c1-6-31-25-32(42(53)45-19-20-56-23-24-57-22-21-55-5)27-33(26-31)47-43-46-18-17-41(50-43)58-39-16-15-37(35-9-7-8-10-36(35)39)48-44(54)49-40-28-38(29(2)3)51-52(40)34-13-11-30(4)12-14-34/h1,7-18,25-29H,19-24H2,2-5H3,(H,45,53)(H,46,47,50)(H2,48,49,54) DANMJMQROKKATM-UHFFFAOYSA-N 392690 3-Ethynyl-5-((4-((4-(3-(3-isopropyl-1-(p-tolyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-N-(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-benzamide::US10301288, Example 1::US10301288, Example 2 Proto-oncogene tyrosine-protein kinase Src Human 11.0 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=13&target=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392690&enzyme=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search 86304173 404961017 1 MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 1FMK,1HCS,1HCT,1O41,1O42,1O43,1O44,1O45,1O46,1O47,1O48,1O49,1O4A,1O4B,1O4C,1O4D,1O4E,1O4F,1O4G,1O4H,1O4I,1O4J,1O4K,1O4L,1O4M,1O4N,1O4O,1O4P,1O4Q,1O4R,1SHA,1SHB,1SHD,1SPR,1SPS,1Y57,1YI6,2BDF,2BDJ,2H8H,2PTK,2SRC,4MXO,4MXX,4OML,4OMO,5OB0,5OB1,6ATE,6E6E,7A34,7A35,7A36,7A37,7A3D,7PVY,7PVZ Proto-oncogene tyrosine-protein kinase Src SRC_HUMAN P12931 E1P5V4 Q76P87 Q86VB9 Q9H5A8 784743 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C44H46N8O6/c1-6-31-25-32(42(53)45-19-20-56-23-24-57-22-21-55-5)27-33(26-31)47-43-46-18-17-41(50-43)58-39-16-15-37(35-9-7-8-10-36(35)39)48-44(54)49-40-28-38(29(2)3)51-52(40)34-13-11-30(4)12-14-34/h1,7-18,25-29H,19-24H2,2-5H3,(H,45,53)(H,46,47,50)(H2,48,49,54) DANMJMQROKKATM-UHFFFAOYSA-N 392690 3-Ethynyl-5-((4-((4-(3-(3-isopropyl-1-(p-tolyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-N-(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-benzamide::US10301288, Example 1::US10301288, Example 2 Tyrosine-protein kinase SYK Homo sapiens 50.0 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=763&target=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392690&enzyme=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search 86304173 404961017 1 MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 1XBA,1XBB,1XBC,3FQE,3FQH,3FQS,3SRV,3TUB,3TUC,3TUD,3VF8,3VF9,4DFL,4DFN,4F4P,4FL1,4FL2,4FYN,4FYO,4FZ6,4FZ7,4GFG,4I0R,4I0S,4I0T,4PUZ,4PV0,4RSS,4WNM,4XG2,4XG3,4XG4,4XG6,4XG7,4XG8,4XG9,4YJO,4YJP,4YJQ,4YJR,4YJS,4YJT,4YJU,4YJV,5C26,5C27,5GHV,5LMA,5LMB,5T68,5TIU,5TR6,5TT7,5Y5T,5Y5U,6HM6,6HM7,6SSB,6VOV,6ZC0,6ZCP,6ZCQ,6ZCR,6ZCS,6ZCU,6ZCX,6ZCY,7SA7,8BI2 Tyrosine-protein kinase SYK KSYK_HUMAN P43405 784744 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C44H46N8O6/c1-6-31-25-32(42(53)45-19-20-56-23-24-57-22-21-55-5)27-33(26-31)47-43-46-18-17-41(50-43)58-39-16-15-37(35-9-7-8-10-36(35)39)48-44(54)49-40-28-38(29(2)3)51-52(40)34-13-11-30(4)12-14-34/h1,7-18,25-29H,19-24H2,2-5H3,(H,45,53)(H,46,47,50)(H2,48,49,54) DANMJMQROKKATM-UHFFFAOYSA-N 392690 3-Ethynyl-5-((4-((4-(3-(3-isopropyl-1-(p-tolyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-N-(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-benzamide::US10301288, Example 1::US10301288, Example 2 Glycogen synthase kinase-3 alpha Homo sapiens 3849 US Patent 10.7270/Q24B33N6 aid1798903 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392690&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 86304173 404961017 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 784745 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(OC)cc4)C(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C44H46N8O7/c1-6-30-25-31(42(53)45-19-20-57-23-24-58-22-21-55-4)27-32(26-30)47-43-46-18-17-41(50-43)59-39-16-15-37(35-9-7-8-10-36(35)39)48-44(54)49-40-28-38(29(2)3)51-52(40)33-11-13-34(56-5)14-12-33/h1,7-18,25-29H,19-24H2,2-5H3,(H,45,53)(H,46,47,50)(H2,48,49,54) QXWLCWKPJNSRRJ-UHFFFAOYSA-N 392692 US10301288, Example 3 Mitogen-activated protein kinase 14 Homo sapiens 39.0 US Patent 10.7270/Q24B33N6 aid1798901 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392692&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 134386384 404961018 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 784746 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(OC)cc4)C(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C44H46N8O7/c1-6-30-25-31(42(53)45-19-20-57-23-24-58-22-21-55-4)27-32(26-30)47-43-46-18-17-41(50-43)59-39-16-15-37(35-9-7-8-10-36(35)39)48-44(54)49-40-28-38(29(2)3)51-52(40)33-11-13-34(56-5)14-12-33/h1,7-18,25-29H,19-24H2,2-5H3,(H,45,53)(H,46,47,50)(H2,48,49,54) QXWLCWKPJNSRRJ-UHFFFAOYSA-N 392692 US10301288, Example 3 Proto-oncogene tyrosine-protein kinase Src Human 14.0 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=13&target=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392692&enzyme=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search 134386384 404961018 1 MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 1FMK,1HCS,1HCT,1O41,1O42,1O43,1O44,1O45,1O46,1O47,1O48,1O49,1O4A,1O4B,1O4C,1O4D,1O4E,1O4F,1O4G,1O4H,1O4I,1O4J,1O4K,1O4L,1O4M,1O4N,1O4O,1O4P,1O4Q,1O4R,1SHA,1SHB,1SHD,1SPR,1SPS,1Y57,1YI6,2BDF,2BDJ,2H8H,2PTK,2SRC,4MXO,4MXX,4OML,4OMO,5OB0,5OB1,6ATE,6E6E,7A34,7A35,7A36,7A37,7A3D,7PVY,7PVZ Proto-oncogene tyrosine-protein kinase Src SRC_HUMAN P12931 E1P5V4 Q76P87 Q86VB9 Q9H5A8 784747 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(OC)cc4)C(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C44H46N8O7/c1-6-30-25-31(42(53)45-19-20-57-23-24-58-22-21-55-4)27-32(26-30)47-43-46-18-17-41(50-43)59-39-16-15-37(35-9-7-8-10-36(35)39)48-44(54)49-40-28-38(29(2)3)51-52(40)33-11-13-34(56-5)14-12-33/h1,7-18,25-29H,19-24H2,2-5H3,(H,45,53)(H,46,47,50)(H2,48,49,54) QXWLCWKPJNSRRJ-UHFFFAOYSA-N 392692 US10301288, Example 3 Tyrosine-protein kinase SYK Homo sapiens 30.0 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=763&target=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392692&enzyme=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search 134386384 404961018 1 MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 1XBA,1XBB,1XBC,3FQE,3FQH,3FQS,3SRV,3TUB,3TUC,3TUD,3VF8,3VF9,4DFL,4DFN,4F4P,4FL1,4FL2,4FYN,4FYO,4FZ6,4FZ7,4GFG,4I0R,4I0S,4I0T,4PUZ,4PV0,4RSS,4WNM,4XG2,4XG3,4XG4,4XG6,4XG7,4XG8,4XG9,4YJO,4YJP,4YJQ,4YJR,4YJS,4YJT,4YJU,4YJV,5C26,5C27,5GHV,5LMA,5LMB,5T68,5TIU,5TR6,5TT7,5Y5T,5Y5U,6HM6,6HM7,6SSB,6VOV,6ZC0,6ZCP,6ZCQ,6ZCR,6ZCS,6ZCU,6ZCX,6ZCY,7SA7,8BI2 Tyrosine-protein kinase SYK KSYK_HUMAN P43405 784748 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(OC)cc4)C(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C44H46N8O7/c1-6-30-25-31(42(53)45-19-20-57-23-24-58-22-21-55-4)27-32(26-30)47-43-46-18-17-41(50-43)59-39-16-15-37(35-9-7-8-10-36(35)39)48-44(54)49-40-28-38(29(2)3)51-52(40)33-11-13-34(56-5)14-12-33/h1,7-18,25-29H,19-24H2,2-5H3,(H,45,53)(H,46,47,50)(H2,48,49,54) QXWLCWKPJNSRRJ-UHFFFAOYSA-N 392692 US10301288, Example 3 Glycogen synthase kinase-3 alpha Homo sapiens 12159 US Patent 10.7270/Q24B33N6 aid1798903 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392692&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 134386384 404961018 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 784749 COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)C)c4ccccc34)ccn2)cc(OC)c1 InChI=1S/C44H49N7O7/c1-29(2)39-28-42(51(50-39)33-12-10-30(3)11-13-33)49-44(53)48-38-14-15-40(37-9-7-6-8-36(37)38)58-34-16-17-45-41(27-34)47-32-24-31(25-35(26-32)55-5)43(52)46-18-19-56-22-23-57-21-20-54-4/h6-17,24-29H,18-23H2,1-5H3,(H,45,47)(H,46,52)(H2,48,49,53) PSKCCPWOWLPVFR-UHFFFAOYSA-N 392693 US10301288, Example 4 Mitogen-activated protein kinase 14 Homo sapiens 50.0 US Patent 10.7270/Q24B33N6 aid1798901 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392693 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392693&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 134386120 404961019 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 784750 COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)C)c4ccccc34)ccn2)cc(OC)c1 InChI=1S/C44H49N7O7/c1-29(2)39-28-42(51(50-39)33-12-10-30(3)11-13-33)49-44(53)48-38-14-15-40(37-9-7-6-8-36(37)38)58-34-16-17-45-41(27-34)47-32-24-31(25-35(26-32)55-5)43(52)46-18-19-56-22-23-57-21-20-54-4/h6-17,24-29H,18-23H2,1-5H3,(H,45,47)(H,46,52)(H2,48,49,53) PSKCCPWOWLPVFR-UHFFFAOYSA-N 392693 US10301288, Example 4 Proto-oncogene tyrosine-protein kinase Src Human 19.0 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392693 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=13&target=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392693&enzyme=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search 134386120 404961019 1 MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 1FMK,1HCS,1HCT,1O41,1O42,1O43,1O44,1O45,1O46,1O47,1O48,1O49,1O4A,1O4B,1O4C,1O4D,1O4E,1O4F,1O4G,1O4H,1O4I,1O4J,1O4K,1O4L,1O4M,1O4N,1O4O,1O4P,1O4Q,1O4R,1SHA,1SHB,1SHD,1SPR,1SPS,1Y57,1YI6,2BDF,2BDJ,2H8H,2PTK,2SRC,4MXO,4MXX,4OML,4OMO,5OB0,5OB1,6ATE,6E6E,7A34,7A35,7A36,7A37,7A3D,7PVY,7PVZ Proto-oncogene tyrosine-protein kinase Src SRC_HUMAN P12931 E1P5V4 Q76P87 Q86VB9 Q9H5A8 784751 COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)C)c4ccccc34)ccn2)cc(OC)c1 InChI=1S/C44H49N7O7/c1-29(2)39-28-42(51(50-39)33-12-10-30(3)11-13-33)49-44(53)48-38-14-15-40(37-9-7-6-8-36(37)38)58-34-16-17-45-41(27-34)47-32-24-31(25-35(26-32)55-5)43(52)46-18-19-56-22-23-57-21-20-54-4/h6-17,24-29H,18-23H2,1-5H3,(H,45,47)(H,46,52)(H2,48,49,53) PSKCCPWOWLPVFR-UHFFFAOYSA-N 392693 US10301288, Example 4 Tyrosine-protein kinase SYK Homo sapiens 46.0 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392693 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=763&target=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392693&enzyme=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search 134386120 404961019 1 MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 1XBA,1XBB,1XBC,3FQE,3FQH,3FQS,3SRV,3TUB,3TUC,3TUD,3VF8,3VF9,4DFL,4DFN,4F4P,4FL1,4FL2,4FYN,4FYO,4FZ6,4FZ7,4GFG,4I0R,4I0S,4I0T,4PUZ,4PV0,4RSS,4WNM,4XG2,4XG3,4XG4,4XG6,4XG7,4XG8,4XG9,4YJO,4YJP,4YJQ,4YJR,4YJS,4YJT,4YJU,4YJV,5C26,5C27,5GHV,5LMA,5LMB,5T68,5TIU,5TR6,5TT7,5Y5T,5Y5U,6HM6,6HM7,6SSB,6VOV,6ZC0,6ZCP,6ZCQ,6ZCR,6ZCS,6ZCU,6ZCX,6ZCY,7SA7,8BI2 Tyrosine-protein kinase SYK KSYK_HUMAN P43405 784752 COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)C)c4ccccc34)ccn2)cc(OC)c1 InChI=1S/C44H49N7O7/c1-29(2)39-28-42(51(50-39)33-12-10-30(3)11-13-33)49-44(53)48-38-14-15-40(37-9-7-6-8-36(37)38)58-34-16-17-45-41(27-34)47-32-24-31(25-35(26-32)55-5)43(52)46-18-19-56-22-23-57-21-20-54-4/h6-17,24-29H,18-23H2,1-5H3,(H,45,47)(H,46,52)(H2,48,49,53) PSKCCPWOWLPVFR-UHFFFAOYSA-N 392693 US10301288, Example 4 Glycogen synthase kinase-3 alpha Homo sapiens 9547 US Patent 10.7270/Q24B33N6 aid1798903 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392693 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392693&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 134386120 404961019 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 784753 COCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(OC)cc4)C(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C42H42N8O6/c1-6-28-23-29(40(51)43-19-20-55-22-21-53-4)25-30(24-28)45-41-44-18-17-39(48-41)56-37-16-15-35(33-9-7-8-10-34(33)37)46-42(52)47-38-26-36(27(2)3)49-50(38)31-11-13-32(54-5)14-12-31/h1,7-18,23-27H,19-22H2,2-5H3,(H,43,51)(H,44,45,48)(H2,46,47,52) KBDMNNVCGCQHGS-UHFFFAOYSA-N 392694 US10301288, Example 5 Mitogen-activated protein kinase 14 Homo sapiens 33.0 US Patent 10.7270/Q24B33N6 aid1798901 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392694 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392694&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 134386387 404961020 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 784754 COCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(OC)cc4)C(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C42H42N8O6/c1-6-28-23-29(40(51)43-19-20-55-22-21-53-4)25-30(24-28)45-41-44-18-17-39(48-41)56-37-16-15-35(33-9-7-8-10-34(33)37)46-42(52)47-38-26-36(27(2)3)49-50(38)31-11-13-32(54-5)14-12-31/h1,7-18,23-27H,19-22H2,2-5H3,(H,43,51)(H,44,45,48)(H2,46,47,52) KBDMNNVCGCQHGS-UHFFFAOYSA-N 392694 US10301288, Example 5 Proto-oncogene tyrosine-protein kinase Src Human 13.0 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392694 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=13&target=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392694&enzyme=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search 134386387 404961020 1 MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 1FMK,1HCS,1HCT,1O41,1O42,1O43,1O44,1O45,1O46,1O47,1O48,1O49,1O4A,1O4B,1O4C,1O4D,1O4E,1O4F,1O4G,1O4H,1O4I,1O4J,1O4K,1O4L,1O4M,1O4N,1O4O,1O4P,1O4Q,1O4R,1SHA,1SHB,1SHD,1SPR,1SPS,1Y57,1YI6,2BDF,2BDJ,2H8H,2PTK,2SRC,4MXO,4MXX,4OML,4OMO,5OB0,5OB1,6ATE,6E6E,7A34,7A35,7A36,7A37,7A3D,7PVY,7PVZ Proto-oncogene tyrosine-protein kinase Src SRC_HUMAN P12931 E1P5V4 Q76P87 Q86VB9 Q9H5A8 784755 COCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(OC)cc4)C(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C42H42N8O6/c1-6-28-23-29(40(51)43-19-20-55-22-21-53-4)25-30(24-28)45-41-44-18-17-39(48-41)56-37-16-15-35(33-9-7-8-10-34(33)37)46-42(52)47-38-26-36(27(2)3)49-50(38)31-11-13-32(54-5)14-12-31/h1,7-18,23-27H,19-22H2,2-5H3,(H,43,51)(H,44,45,48)(H2,46,47,52) KBDMNNVCGCQHGS-UHFFFAOYSA-N 392694 US10301288, Example 5 Tyrosine-protein kinase SYK Homo sapiens 34.0 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392694 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=763&target=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392694&enzyme=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search 134386387 404961020 1 MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 1XBA,1XBB,1XBC,3FQE,3FQH,3FQS,3SRV,3TUB,3TUC,3TUD,3VF8,3VF9,4DFL,4DFN,4F4P,4FL1,4FL2,4FYN,4FYO,4FZ6,4FZ7,4GFG,4I0R,4I0S,4I0T,4PUZ,4PV0,4RSS,4WNM,4XG2,4XG3,4XG4,4XG6,4XG7,4XG8,4XG9,4YJO,4YJP,4YJQ,4YJR,4YJS,4YJT,4YJU,4YJV,5C26,5C27,5GHV,5LMA,5LMB,5T68,5TIU,5TR6,5TT7,5Y5T,5Y5U,6HM6,6HM7,6SSB,6VOV,6ZC0,6ZCP,6ZCQ,6ZCR,6ZCS,6ZCU,6ZCX,6ZCY,7SA7,8BI2 Tyrosine-protein kinase SYK KSYK_HUMAN P43405 784756 COCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(OC)cc4)C(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C42H42N8O6/c1-6-28-23-29(40(51)43-19-20-55-22-21-53-4)25-30(24-28)45-41-44-18-17-39(48-41)56-37-16-15-35(33-9-7-8-10-34(33)37)46-42(52)47-38-26-36(27(2)3)49-50(38)31-11-13-32(54-5)14-12-31/h1,7-18,23-27H,19-22H2,2-5H3,(H,43,51)(H,44,45,48)(H2,46,47,52) KBDMNNVCGCQHGS-UHFFFAOYSA-N 392694 US10301288, Example 5 Glycogen synthase kinase-3 alpha Homo sapiens 13006 US Patent 10.7270/Q24B33N6 aid1798903 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392694 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392694&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 134386387 404961020 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 784757 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C45H48N8O6/c1-7-31-26-32(42(54)46-20-21-57-24-25-58-23-22-56-6)28-33(27-31)48-43-47-19-18-41(51-43)59-38-17-16-37(35-10-8-9-11-36(35)38)49-44(55)50-40-29-39(45(3,4)5)52-53(40)34-14-12-30(2)13-15-34/h1,8-19,26-29H,20-25H2,2-6H3,(H,46,54)(H,47,48,51)(H2,49,50,55) MMBUUNLZGRAVKE-UHFFFAOYSA-N 392695 US10301288, Example 12::US10301288, Example 6 Mitogen-activated protein kinase 14 Homo sapiens 42.0 US Patent 10.7270/Q24B33N6 aid1798901 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392695&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 86304332 404961021 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 784758 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C45H48N8O6/c1-7-31-26-32(42(54)46-20-21-57-24-25-58-23-22-56-6)28-33(27-31)48-43-47-19-18-41(51-43)59-38-17-16-37(35-10-8-9-11-36(35)38)49-44(55)50-40-29-39(45(3,4)5)52-53(40)34-14-12-30(2)13-15-34/h1,8-19,26-29H,20-25H2,2-6H3,(H,46,54)(H,47,48,51)(H2,49,50,55) MMBUUNLZGRAVKE-UHFFFAOYSA-N 392695 US10301288, Example 12::US10301288, Example 6 Proto-oncogene tyrosine-protein kinase Src Human 17.0 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=13&target=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392695&enzyme=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search 86304332 404961021 1 MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 1FMK,1HCS,1HCT,1O41,1O42,1O43,1O44,1O45,1O46,1O47,1O48,1O49,1O4A,1O4B,1O4C,1O4D,1O4E,1O4F,1O4G,1O4H,1O4I,1O4J,1O4K,1O4L,1O4M,1O4N,1O4O,1O4P,1O4Q,1O4R,1SHA,1SHB,1SHD,1SPR,1SPS,1Y57,1YI6,2BDF,2BDJ,2H8H,2PTK,2SRC,4MXO,4MXX,4OML,4OMO,5OB0,5OB1,6ATE,6E6E,7A34,7A35,7A36,7A37,7A3D,7PVY,7PVZ Proto-oncogene tyrosine-protein kinase Src SRC_HUMAN P12931 E1P5V4 Q76P87 Q86VB9 Q9H5A8 784759 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C45H48N8O6/c1-7-31-26-32(42(54)46-20-21-57-24-25-58-23-22-56-6)28-33(27-31)48-43-47-19-18-41(51-43)59-38-17-16-37(35-10-8-9-11-36(35)38)49-44(55)50-40-29-39(45(3,4)5)52-53(40)34-14-12-30(2)13-15-34/h1,8-19,26-29H,20-25H2,2-6H3,(H,46,54)(H,47,48,51)(H2,49,50,55) MMBUUNLZGRAVKE-UHFFFAOYSA-N 392695 US10301288, Example 12::US10301288, Example 6 Tyrosine-protein kinase SYK Homo sapiens 96.0 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=763&target=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392695&enzyme=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search 86304332 404961021 1 MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 1XBA,1XBB,1XBC,3FQE,3FQH,3FQS,3SRV,3TUB,3TUC,3TUD,3VF8,3VF9,4DFL,4DFN,4F4P,4FL1,4FL2,4FYN,4FYO,4FZ6,4FZ7,4GFG,4I0R,4I0S,4I0T,4PUZ,4PV0,4RSS,4WNM,4XG2,4XG3,4XG4,4XG6,4XG7,4XG8,4XG9,4YJO,4YJP,4YJQ,4YJR,4YJS,4YJT,4YJU,4YJV,5C26,5C27,5GHV,5LMA,5LMB,5T68,5TIU,5TR6,5TT7,5Y5T,5Y5U,6HM6,6HM7,6SSB,6VOV,6ZC0,6ZCP,6ZCQ,6ZCR,6ZCS,6ZCU,6ZCX,6ZCY,7SA7,8BI2 Tyrosine-protein kinase SYK KSYK_HUMAN P43405 784760 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C45H48N8O6/c1-7-31-26-32(42(54)46-20-21-57-24-25-58-23-22-56-6)28-33(27-31)48-43-47-19-18-41(51-43)59-38-17-16-37(35-10-8-9-11-36(35)38)49-44(55)50-40-29-39(45(3,4)5)52-53(40)34-14-12-30(2)13-15-34/h1,8-19,26-29H,20-25H2,2-6H3,(H,46,54)(H,47,48,51)(H2,49,50,55) MMBUUNLZGRAVKE-UHFFFAOYSA-N 392695 US10301288, Example 12::US10301288, Example 6 Glycogen synthase kinase-3 alpha Homo sapiens 1695 US Patent 10.7270/Q24B33N6 aid1798903 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392695&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 86304332 404961021 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 784761 COCCOCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C47H52N8O7/c1-7-33-28-34(44(56)48-20-21-59-24-25-61-27-26-60-23-22-58-6)30-35(29-33)50-45-49-19-18-43(53-45)62-40-17-16-39(37-10-8-9-11-38(37)40)51-46(57)52-42-31-41(47(3,4)5)54-55(42)36-14-12-32(2)13-15-36/h1,8-19,28-31H,20-27H2,2-6H3,(H,48,56)(H,49,50,53)(H2,51,52,57) UEIRWEKIHPJJKK-UHFFFAOYSA-N 392696 US10301288, Example 7 Mitogen-activated protein kinase 14 Homo sapiens 88.0 US Patent 10.7270/Q24B33N6 aid1798901 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392696 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392696&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 86304482 404961022 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 784762 COCCOCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C47H52N8O7/c1-7-33-28-34(44(56)48-20-21-59-24-25-61-27-26-60-23-22-58-6)30-35(29-33)50-45-49-19-18-43(53-45)62-40-17-16-39(37-10-8-9-11-38(37)40)51-46(57)52-42-31-41(47(3,4)5)54-55(42)36-14-12-32(2)13-15-36/h1,8-19,28-31H,20-27H2,2-6H3,(H,48,56)(H,49,50,53)(H2,51,52,57) UEIRWEKIHPJJKK-UHFFFAOYSA-N 392696 US10301288, Example 7 Proto-oncogene tyrosine-protein kinase Src Human 18.0 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392696 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=13&target=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392696&enzyme=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search 86304482 404961022 1 MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 1FMK,1HCS,1HCT,1O41,1O42,1O43,1O44,1O45,1O46,1O47,1O48,1O49,1O4A,1O4B,1O4C,1O4D,1O4E,1O4F,1O4G,1O4H,1O4I,1O4J,1O4K,1O4L,1O4M,1O4N,1O4O,1O4P,1O4Q,1O4R,1SHA,1SHB,1SHD,1SPR,1SPS,1Y57,1YI6,2BDF,2BDJ,2H8H,2PTK,2SRC,4MXO,4MXX,4OML,4OMO,5OB0,5OB1,6ATE,6E6E,7A34,7A35,7A36,7A37,7A3D,7PVY,7PVZ Proto-oncogene tyrosine-protein kinase Src SRC_HUMAN P12931 E1P5V4 Q76P87 Q86VB9 Q9H5A8 784763 COCCOCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C47H52N8O7/c1-7-33-28-34(44(56)48-20-21-59-24-25-61-27-26-60-23-22-58-6)30-35(29-33)50-45-49-19-18-43(53-45)62-40-17-16-39(37-10-8-9-11-38(37)40)51-46(57)52-42-31-41(47(3,4)5)54-55(42)36-14-12-32(2)13-15-36/h1,8-19,28-31H,20-27H2,2-6H3,(H,48,56)(H,49,50,53)(H2,51,52,57) UEIRWEKIHPJJKK-UHFFFAOYSA-N 392696 US10301288, Example 7 Tyrosine-protein kinase SYK Homo sapiens 237 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392696 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=763&target=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392696&enzyme=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search 86304482 404961022 1 MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 1XBA,1XBB,1XBC,3FQE,3FQH,3FQS,3SRV,3TUB,3TUC,3TUD,3VF8,3VF9,4DFL,4DFN,4F4P,4FL1,4FL2,4FYN,4FYO,4FZ6,4FZ7,4GFG,4I0R,4I0S,4I0T,4PUZ,4PV0,4RSS,4WNM,4XG2,4XG3,4XG4,4XG6,4XG7,4XG8,4XG9,4YJO,4YJP,4YJQ,4YJR,4YJS,4YJT,4YJU,4YJV,5C26,5C27,5GHV,5LMA,5LMB,5T68,5TIU,5TR6,5TT7,5Y5T,5Y5U,6HM6,6HM7,6SSB,6VOV,6ZC0,6ZCP,6ZCQ,6ZCR,6ZCS,6ZCU,6ZCX,6ZCY,7SA7,8BI2 Tyrosine-protein kinase SYK KSYK_HUMAN P43405 784764 COCCOCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C47H52N8O7/c1-7-33-28-34(44(56)48-20-21-59-24-25-61-27-26-60-23-22-58-6)30-35(29-33)50-45-49-19-18-43(53-45)62-40-17-16-39(37-10-8-9-11-38(37)40)51-46(57)52-42-31-41(47(3,4)5)54-55(42)36-14-12-32(2)13-15-36/h1,8-19,28-31H,20-27H2,2-6H3,(H,48,56)(H,49,50,53)(H2,51,52,57) UEIRWEKIHPJJKK-UHFFFAOYSA-N 392696 US10301288, Example 7 Glycogen synthase kinase-3 alpha Homo sapiens 2020 US Patent 10.7270/Q24B33N6 aid1798903 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392696 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392696&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 86304482 404961022 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 784765 COCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C43H44N8O5/c1-7-29-24-30(40(52)44-20-21-55-23-22-54-6)26-31(25-29)46-41-45-19-18-39(49-41)56-36-17-16-35(33-10-8-9-11-34(33)36)47-42(53)48-38-27-37(43(3,4)5)50-51(38)32-14-12-28(2)13-15-32/h1,8-19,24-27H,20-23H2,2-6H3,(H,44,52)(H,45,46,49)(H2,47,48,53) YOSOEKMQFOYUKT-UHFFFAOYSA-N 392697 US10301288, Example 8 Mitogen-activated protein kinase 14 Homo sapiens 104 US Patent 10.7270/Q24B33N6 aid1798901 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392697 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392697&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 86304481 404961023 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 784766 COCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C43H44N8O5/c1-7-29-24-30(40(52)44-20-21-55-23-22-54-6)26-31(25-29)46-41-45-19-18-39(49-41)56-36-17-16-35(33-10-8-9-11-34(33)36)47-42(53)48-38-27-37(43(3,4)5)50-51(38)32-14-12-28(2)13-15-32/h1,8-19,24-27H,20-23H2,2-6H3,(H,44,52)(H,45,46,49)(H2,47,48,53) YOSOEKMQFOYUKT-UHFFFAOYSA-N 392697 US10301288, Example 8 Proto-oncogene tyrosine-protein kinase Src Human 20.0 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392697 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=13&target=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392697&enzyme=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search 86304481 404961023 1 MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 1FMK,1HCS,1HCT,1O41,1O42,1O43,1O44,1O45,1O46,1O47,1O48,1O49,1O4A,1O4B,1O4C,1O4D,1O4E,1O4F,1O4G,1O4H,1O4I,1O4J,1O4K,1O4L,1O4M,1O4N,1O4O,1O4P,1O4Q,1O4R,1SHA,1SHB,1SHD,1SPR,1SPS,1Y57,1YI6,2BDF,2BDJ,2H8H,2PTK,2SRC,4MXO,4MXX,4OML,4OMO,5OB0,5OB1,6ATE,6E6E,7A34,7A35,7A36,7A37,7A3D,7PVY,7PVZ Proto-oncogene tyrosine-protein kinase Src SRC_HUMAN P12931 E1P5V4 Q76P87 Q86VB9 Q9H5A8 784767 COCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C43H44N8O5/c1-7-29-24-30(40(52)44-20-21-55-23-22-54-6)26-31(25-29)46-41-45-19-18-39(49-41)56-36-17-16-35(33-10-8-9-11-34(33)36)47-42(53)48-38-27-37(43(3,4)5)50-51(38)32-14-12-28(2)13-15-32/h1,8-19,24-27H,20-23H2,2-6H3,(H,44,52)(H,45,46,49)(H2,47,48,53) YOSOEKMQFOYUKT-UHFFFAOYSA-N 392697 US10301288, Example 8 Tyrosine-protein kinase SYK Homo sapiens 120 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392697 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=763&target=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392697&enzyme=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search 86304481 404961023 1 MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 1XBA,1XBB,1XBC,3FQE,3FQH,3FQS,3SRV,3TUB,3TUC,3TUD,3VF8,3VF9,4DFL,4DFN,4F4P,4FL1,4FL2,4FYN,4FYO,4FZ6,4FZ7,4GFG,4I0R,4I0S,4I0T,4PUZ,4PV0,4RSS,4WNM,4XG2,4XG3,4XG4,4XG6,4XG7,4XG8,4XG9,4YJO,4YJP,4YJQ,4YJR,4YJS,4YJT,4YJU,4YJV,5C26,5C27,5GHV,5LMA,5LMB,5T68,5TIU,5TR6,5TT7,5Y5T,5Y5U,6HM6,6HM7,6SSB,6VOV,6ZC0,6ZCP,6ZCQ,6ZCR,6ZCS,6ZCU,6ZCX,6ZCY,7SA7,8BI2 Tyrosine-protein kinase SYK KSYK_HUMAN P43405 784768 COCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C43H44N8O5/c1-7-29-24-30(40(52)44-20-21-55-23-22-54-6)26-31(25-29)46-41-45-19-18-39(49-41)56-36-17-16-35(33-10-8-9-11-34(33)36)47-42(53)48-38-27-37(43(3,4)5)50-51(38)32-14-12-28(2)13-15-32/h1,8-19,24-27H,20-23H2,2-6H3,(H,44,52)(H,45,46,49)(H2,47,48,53) YOSOEKMQFOYUKT-UHFFFAOYSA-N 392697 US10301288, Example 8 Glycogen synthase kinase-3 alpha Homo sapiens 2890 US Patent 10.7270/Q24B33N6 aid1798903 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392697 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392697&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 86304481 404961023 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 784769 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(cc4)N(C)C)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C46H51N9O6/c1-8-31-27-32(43(56)47-21-22-59-25-26-60-24-23-58-7)29-33(28-31)49-44-48-20-19-42(52-44)61-39-18-17-38(36-11-9-10-12-37(36)39)50-45(57)51-41-30-40(46(2,3)4)53-55(41)35-15-13-34(14-16-35)54(5)6/h1,9-20,27-30H,21-26H2,2-7H3,(H,47,56)(H,48,49,52)(H2,50,51,57) HJVPPUMLJXFSJF-UHFFFAOYSA-N 392698 3-((4-((4-(3-(3-(tert-Butyl)-1-(4-(dimethylamino)phenyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-5-ethynyl-N-(2-(2-(2-methoxyethoxy)-ethoxy)ethyl)benzamide::US10301288, Example 9 Mitogen-activated protein kinase 14 Homo sapiens 98.0 US Patent 10.7270/Q24B33N6 aid1798901 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392698&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 86304483 404961024 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 784770 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(cc4)N(C)C)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C46H51N9O6/c1-8-31-27-32(43(56)47-21-22-59-25-26-60-24-23-58-7)29-33(28-31)49-44-48-20-19-42(52-44)61-39-18-17-38(36-11-9-10-12-37(36)39)50-45(57)51-41-30-40(46(2,3)4)53-55(41)35-15-13-34(14-16-35)54(5)6/h1,9-20,27-30H,21-26H2,2-7H3,(H,47,56)(H,48,49,52)(H2,50,51,57) HJVPPUMLJXFSJF-UHFFFAOYSA-N 392698 3-((4-((4-(3-(3-(tert-Butyl)-1-(4-(dimethylamino)phenyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-5-ethynyl-N-(2-(2-(2-methoxyethoxy)-ethoxy)ethyl)benzamide::US10301288, Example 9 Proto-oncogene tyrosine-protein kinase Src Human 15.0 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=13&target=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392698&enzyme=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search 86304483 404961024 1 MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 1FMK,1HCS,1HCT,1O41,1O42,1O43,1O44,1O45,1O46,1O47,1O48,1O49,1O4A,1O4B,1O4C,1O4D,1O4E,1O4F,1O4G,1O4H,1O4I,1O4J,1O4K,1O4L,1O4M,1O4N,1O4O,1O4P,1O4Q,1O4R,1SHA,1SHB,1SHD,1SPR,1SPS,1Y57,1YI6,2BDF,2BDJ,2H8H,2PTK,2SRC,4MXO,4MXX,4OML,4OMO,5OB0,5OB1,6ATE,6E6E,7A34,7A35,7A36,7A37,7A3D,7PVY,7PVZ Proto-oncogene tyrosine-protein kinase Src SRC_HUMAN P12931 E1P5V4 Q76P87 Q86VB9 Q9H5A8 784771 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(cc4)N(C)C)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C46H51N9O6/c1-8-31-27-32(43(56)47-21-22-59-25-26-60-24-23-58-7)29-33(28-31)49-44-48-20-19-42(52-44)61-39-18-17-38(36-11-9-10-12-37(36)39)50-45(57)51-41-30-40(46(2,3)4)53-55(41)35-15-13-34(14-16-35)54(5)6/h1,9-20,27-30H,21-26H2,2-7H3,(H,47,56)(H,48,49,52)(H2,50,51,57) HJVPPUMLJXFSJF-UHFFFAOYSA-N 392698 3-((4-((4-(3-(3-(tert-Butyl)-1-(4-(dimethylamino)phenyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-5-ethynyl-N-(2-(2-(2-methoxyethoxy)-ethoxy)ethyl)benzamide::US10301288, Example 9 Tyrosine-protein kinase SYK Homo sapiens 35.0 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=763&target=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392698&enzyme=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search 86304483 404961024 1 MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 1XBA,1XBB,1XBC,3FQE,3FQH,3FQS,3SRV,3TUB,3TUC,3TUD,3VF8,3VF9,4DFL,4DFN,4F4P,4FL1,4FL2,4FYN,4FYO,4FZ6,4FZ7,4GFG,4I0R,4I0S,4I0T,4PUZ,4PV0,4RSS,4WNM,4XG2,4XG3,4XG4,4XG6,4XG7,4XG8,4XG9,4YJO,4YJP,4YJQ,4YJR,4YJS,4YJT,4YJU,4YJV,5C26,5C27,5GHV,5LMA,5LMB,5T68,5TIU,5TR6,5TT7,5Y5T,5Y5U,6HM6,6HM7,6SSB,6VOV,6ZC0,6ZCP,6ZCQ,6ZCR,6ZCS,6ZCU,6ZCX,6ZCY,7SA7,8BI2 Tyrosine-protein kinase SYK KSYK_HUMAN P43405 784772 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(cc4)N(C)C)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C46H51N9O6/c1-8-31-27-32(43(56)47-21-22-59-25-26-60-24-23-58-7)29-33(28-31)49-44-48-20-19-42(52-44)61-39-18-17-38(36-11-9-10-12-37(36)39)50-45(57)51-41-30-40(46(2,3)4)53-55(41)35-15-13-34(14-16-35)54(5)6/h1,9-20,27-30H,21-26H2,2-7H3,(H,47,56)(H,48,49,52)(H2,50,51,57) HJVPPUMLJXFSJF-UHFFFAOYSA-N 392698 3-((4-((4-(3-(3-(tert-Butyl)-1-(4-(dimethylamino)phenyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-5-ethynyl-N-(2-(2-(2-methoxyethoxy)-ethoxy)ethyl)benzamide::US10301288, Example 9 Glycogen synthase kinase-3 alpha Homo sapiens 12107 US Patent 10.7270/Q24B33N6 aid1798903 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392698&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 86304483 404961024 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 784773 COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(cc4)N(C)C)C(C)(C)C)c4ccccc34)ccn2)cc(OC)c1 InChI=1S/C46H54N8O7/c1-46(2,3)41-30-43(54(52-41)34-14-12-33(13-15-34)53(4)5)51-45(56)50-39-16-17-40(38-11-9-8-10-37(38)39)61-35-18-19-47-42(29-35)49-32-26-31(27-36(28-32)58-7)44(55)48-20-21-59-24-25-60-23-22-57-6/h8-19,26-30H,20-25H2,1-7H3,(H,47,49)(H,48,55)(H2,50,51,56) HBXDHVBDRZTGPO-UHFFFAOYSA-N 392699 3-((4-((4-(3-(3-(tert-Butyl)-1-(4-(dimethylamino)phenyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyridin-2-yl)amino)-5-methoxy-N-(2-(2-(2-methoxyethoxy)-ethoxy)ethyl)benzamide::US10301288, Example 10 Mitogen-activated protein kinase 14 Homo sapiens 110 US Patent 10.7270/Q24B33N6 aid1798901 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392699 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392699&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 86304647 404961025 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 784774 COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(cc4)N(C)C)C(C)(C)C)c4ccccc34)ccn2)cc(OC)c1 InChI=1S/C46H54N8O7/c1-46(2,3)41-30-43(54(52-41)34-14-12-33(13-15-34)53(4)5)51-45(56)50-39-16-17-40(38-11-9-8-10-37(38)39)61-35-18-19-47-42(29-35)49-32-26-31(27-36(28-32)58-7)44(55)48-20-21-59-24-25-60-23-22-57-6/h8-19,26-30H,20-25H2,1-7H3,(H,47,49)(H,48,55)(H2,50,51,56) HBXDHVBDRZTGPO-UHFFFAOYSA-N 392699 3-((4-((4-(3-(3-(tert-Butyl)-1-(4-(dimethylamino)phenyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyridin-2-yl)amino)-5-methoxy-N-(2-(2-(2-methoxyethoxy)-ethoxy)ethyl)benzamide::US10301288, Example 10 Proto-oncogene tyrosine-protein kinase Src Human 25.0 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392699 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=13&target=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392699&enzyme=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search 86304647 404961025 1 MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 1FMK,1HCS,1HCT,1O41,1O42,1O43,1O44,1O45,1O46,1O47,1O48,1O49,1O4A,1O4B,1O4C,1O4D,1O4E,1O4F,1O4G,1O4H,1O4I,1O4J,1O4K,1O4L,1O4M,1O4N,1O4O,1O4P,1O4Q,1O4R,1SHA,1SHB,1SHD,1SPR,1SPS,1Y57,1YI6,2BDF,2BDJ,2H8H,2PTK,2SRC,4MXO,4MXX,4OML,4OMO,5OB0,5OB1,6ATE,6E6E,7A34,7A35,7A36,7A37,7A3D,7PVY,7PVZ Proto-oncogene tyrosine-protein kinase Src SRC_HUMAN P12931 E1P5V4 Q76P87 Q86VB9 Q9H5A8 784775 COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(cc4)N(C)C)C(C)(C)C)c4ccccc34)ccn2)cc(OC)c1 InChI=1S/C46H54N8O7/c1-46(2,3)41-30-43(54(52-41)34-14-12-33(13-15-34)53(4)5)51-45(56)50-39-16-17-40(38-11-9-8-10-37(38)39)61-35-18-19-47-42(29-35)49-32-26-31(27-36(28-32)58-7)44(55)48-20-21-59-24-25-60-23-22-57-6/h8-19,26-30H,20-25H2,1-7H3,(H,47,49)(H,48,55)(H2,50,51,56) HBXDHVBDRZTGPO-UHFFFAOYSA-N 392699 3-((4-((4-(3-(3-(tert-Butyl)-1-(4-(dimethylamino)phenyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyridin-2-yl)amino)-5-methoxy-N-(2-(2-(2-methoxyethoxy)-ethoxy)ethyl)benzamide::US10301288, Example 10 Tyrosine-protein kinase SYK Homo sapiens 48.0 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392699 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=763&target=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392699&enzyme=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search 86304647 404961025 1 MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 1XBA,1XBB,1XBC,3FQE,3FQH,3FQS,3SRV,3TUB,3TUC,3TUD,3VF8,3VF9,4DFL,4DFN,4F4P,4FL1,4FL2,4FYN,4FYO,4FZ6,4FZ7,4GFG,4I0R,4I0S,4I0T,4PUZ,4PV0,4RSS,4WNM,4XG2,4XG3,4XG4,4XG6,4XG7,4XG8,4XG9,4YJO,4YJP,4YJQ,4YJR,4YJS,4YJT,4YJU,4YJV,5C26,5C27,5GHV,5LMA,5LMB,5T68,5TIU,5TR6,5TT7,5Y5T,5Y5U,6HM6,6HM7,6SSB,6VOV,6ZC0,6ZCP,6ZCQ,6ZCR,6ZCS,6ZCU,6ZCX,6ZCY,7SA7,8BI2 Tyrosine-protein kinase SYK KSYK_HUMAN P43405 784776 COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(cc4)N(C)C)C(C)(C)C)c4ccccc34)ccn2)cc(OC)c1 InChI=1S/C46H54N8O7/c1-46(2,3)41-30-43(54(52-41)34-14-12-33(13-15-34)53(4)5)51-45(56)50-39-16-17-40(38-11-9-8-10-37(38)39)61-35-18-19-47-42(29-35)49-32-26-31(27-36(28-32)58-7)44(55)48-20-21-59-24-25-60-23-22-57-6/h8-19,26-30H,20-25H2,1-7H3,(H,47,49)(H,48,55)(H2,50,51,56) HBXDHVBDRZTGPO-UHFFFAOYSA-N 392699 3-((4-((4-(3-(3-(tert-Butyl)-1-(4-(dimethylamino)phenyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyridin-2-yl)amino)-5-methoxy-N-(2-(2-(2-methoxyethoxy)-ethoxy)ethyl)benzamide::US10301288, Example 10 Glycogen synthase kinase-3 alpha Homo sapiens 12034 US Patent 10.7270/Q24B33N6 aid1798903 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392699 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392699&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 86304647 404961025 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 784777 COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(cc4)N(C)C)C(C)(C)C)c4ccccc34)ccn2)cc(c1)C#C InChI=1S/C47H52N8O6/c1-8-32-27-33(45(56)49-21-22-59-25-26-60-24-23-58-7)29-34(28-32)50-43-30-37(19-20-48-43)61-41-18-17-40(38-11-9-10-12-39(38)41)51-46(57)52-44-31-42(47(2,3)4)53-55(44)36-15-13-35(14-16-36)54(5)6/h1,9-20,27-31H,21-26H2,2-7H3,(H,48,50)(H,49,56)(H2,51,52,57) VMDRWYXXIHUBBI-UHFFFAOYSA-N 392700 3-((4-((4-(3-(3-(tert-Butyl)-1-(4-(dimethylamino)phenyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyridin-2-yl)amino)-5-ethynyl-N-(2-(2-(2-methoxyethoxy)ethoxy)-ethyl)benzamide::US10301288, Example 11 Mitogen-activated protein kinase 14 Homo sapiens 766 US Patent 10.7270/Q24B33N6 aid1798901 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392700&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 86304648 404961026 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 784778 COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(cc4)N(C)C)C(C)(C)C)c4ccccc34)ccn2)cc(c1)C#C InChI=1S/C47H52N8O6/c1-8-32-27-33(45(56)49-21-22-59-25-26-60-24-23-58-7)29-34(28-32)50-43-30-37(19-20-48-43)61-41-18-17-40(38-11-9-10-12-39(38)41)51-46(57)52-44-31-42(47(2,3)4)53-55(44)36-15-13-35(14-16-36)54(5)6/h1,9-20,27-31H,21-26H2,2-7H3,(H,48,50)(H,49,56)(H2,51,52,57) VMDRWYXXIHUBBI-UHFFFAOYSA-N 392700 3-((4-((4-(3-(3-(tert-Butyl)-1-(4-(dimethylamino)phenyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyridin-2-yl)amino)-5-ethynyl-N-(2-(2-(2-methoxyethoxy)ethoxy)-ethyl)benzamide::US10301288, Example 11 Proto-oncogene tyrosine-protein kinase Src Human >1212 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=13&target=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392700&enzyme=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search 86304648 404961026 1 MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 1FMK,1HCS,1HCT,1O41,1O42,1O43,1O44,1O45,1O46,1O47,1O48,1O49,1O4A,1O4B,1O4C,1O4D,1O4E,1O4F,1O4G,1O4H,1O4I,1O4J,1O4K,1O4L,1O4M,1O4N,1O4O,1O4P,1O4Q,1O4R,1SHA,1SHB,1SHD,1SPR,1SPS,1Y57,1YI6,2BDF,2BDJ,2H8H,2PTK,2SRC,4MXO,4MXX,4OML,4OMO,5OB0,5OB1,6ATE,6E6E,7A34,7A35,7A36,7A37,7A3D,7PVY,7PVZ Proto-oncogene tyrosine-protein kinase Src SRC_HUMAN P12931 E1P5V4 Q76P87 Q86VB9 Q9H5A8 784779 COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(cc4)N(C)C)C(C)(C)C)c4ccccc34)ccn2)cc(c1)C#C InChI=1S/C47H52N8O6/c1-8-32-27-33(45(56)49-21-22-59-25-26-60-24-23-58-7)29-34(28-32)50-43-30-37(19-20-48-43)61-41-18-17-40(38-11-9-10-12-39(38)41)51-46(57)52-44-31-42(47(2,3)4)53-55(44)36-15-13-35(14-16-36)54(5)6/h1,9-20,27-31H,21-26H2,2-7H3,(H,48,50)(H,49,56)(H2,51,52,57) VMDRWYXXIHUBBI-UHFFFAOYSA-N 392700 3-((4-((4-(3-(3-(tert-Butyl)-1-(4-(dimethylamino)phenyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyridin-2-yl)amino)-5-ethynyl-N-(2-(2-(2-methoxyethoxy)ethoxy)-ethyl)benzamide::US10301288, Example 11 Tyrosine-protein kinase SYK Homo sapiens >1212 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=763&target=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392700&enzyme=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search 86304648 404961026 1 MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 1XBA,1XBB,1XBC,3FQE,3FQH,3FQS,3SRV,3TUB,3TUC,3TUD,3VF8,3VF9,4DFL,4DFN,4F4P,4FL1,4FL2,4FYN,4FYO,4FZ6,4FZ7,4GFG,4I0R,4I0S,4I0T,4PUZ,4PV0,4RSS,4WNM,4XG2,4XG3,4XG4,4XG6,4XG7,4XG8,4XG9,4YJO,4YJP,4YJQ,4YJR,4YJS,4YJT,4YJU,4YJV,5C26,5C27,5GHV,5LMA,5LMB,5T68,5TIU,5TR6,5TT7,5Y5T,5Y5U,6HM6,6HM7,6SSB,6VOV,6ZC0,6ZCP,6ZCQ,6ZCR,6ZCS,6ZCU,6ZCX,6ZCY,7SA7,8BI2 Tyrosine-protein kinase SYK KSYK_HUMAN P43405 784780 COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(cc4)N(C)C)C(C)(C)C)c4ccccc34)ccn2)cc(c1)C#C InChI=1S/C47H52N8O6/c1-8-32-27-33(45(56)49-21-22-59-25-26-60-24-23-58-7)29-34(28-32)50-43-30-37(19-20-48-43)61-41-18-17-40(38-11-9-10-12-39(38)41)51-46(57)52-44-31-42(47(2,3)4)53-55(44)36-15-13-35(14-16-36)54(5)6/h1,9-20,27-31H,21-26H2,2-7H3,(H,48,50)(H,49,56)(H2,51,52,57) VMDRWYXXIHUBBI-UHFFFAOYSA-N 392700 3-((4-((4-(3-(3-(tert-Butyl)-1-(4-(dimethylamino)phenyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyridin-2-yl)amino)-5-ethynyl-N-(2-(2-(2-methoxyethoxy)ethoxy)-ethyl)benzamide::US10301288, Example 11 Glycogen synthase kinase-3 alpha Homo sapiens 12122 US Patent 10.7270/Q24B33N6 aid1798903 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392700&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 86304648 404961026 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 784781 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(C)cc4)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C45H48N8O6/c1-7-31-26-32(42(54)46-20-21-57-24-25-58-23-22-56-6)28-33(27-31)48-43-47-19-18-41(51-43)59-38-17-16-37(35-10-8-9-11-36(35)38)49-44(55)50-40-29-39(45(3,4)5)52-53(40)34-14-12-30(2)13-15-34/h1,8-19,26-29H,20-25H2,2-6H3,(H,46,54)(H,47,48,51)(H2,49,50,55) MMBUUNLZGRAVKE-UHFFFAOYSA-N 392695 US10301288, Example 12::US10301288, Example 6 Glycogen synthase kinase-3 alpha Homo sapiens 12485 US Patent 10.7270/Q24B33N6 aid1798903 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392695&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 86304332 404961021 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 784782 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(OC)cc4OC)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C46H50N8O8/c1-8-30-25-31(43(55)47-19-20-60-23-24-61-22-21-57-5)27-32(26-30)49-44-48-18-17-42(52-44)62-38-16-14-36(34-11-9-10-12-35(34)38)50-45(56)51-41-29-40(46(2,3)4)53-54(41)37-15-13-33(58-6)28-39(37)59-7/h1,9-18,25-29H,19-24H2,2-7H3,(H,47,55)(H,48,49,52)(H2,50,51,56) MQJCGMXEGJYQKF-UHFFFAOYSA-N 392702 3-((4-((4-(3-(3-(tert-Butyl)-1-(2,4-dimethoxyphenyl)-1H-pyrazol-5-yl)ureido)naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-5-ethynyl-N-(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-benzamide::US10301288, Example 13 Mitogen-activated protein kinase 14 Homo sapiens 370 US Patent 10.7270/Q24B33N6 aid1798901 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392702&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 86304818 404961027 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 784783 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(OC)cc4OC)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C46H50N8O8/c1-8-30-25-31(43(55)47-19-20-60-23-24-61-22-21-57-5)27-32(26-30)49-44-48-18-17-42(52-44)62-38-16-14-36(34-11-9-10-12-35(34)38)50-45(56)51-41-29-40(46(2,3)4)53-54(41)37-15-13-33(58-6)28-39(37)59-7/h1,9-18,25-29H,19-24H2,2-7H3,(H,47,55)(H,48,49,52)(H2,50,51,56) MQJCGMXEGJYQKF-UHFFFAOYSA-N 392702 3-((4-((4-(3-(3-(tert-Butyl)-1-(2,4-dimethoxyphenyl)-1H-pyrazol-5-yl)ureido)naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-5-ethynyl-N-(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-benzamide::US10301288, Example 13 Proto-oncogene tyrosine-protein kinase Src Human 21.0 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=13&target=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392702&enzyme=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search 86304818 404961027 1 MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 1FMK,1HCS,1HCT,1O41,1O42,1O43,1O44,1O45,1O46,1O47,1O48,1O49,1O4A,1O4B,1O4C,1O4D,1O4E,1O4F,1O4G,1O4H,1O4I,1O4J,1O4K,1O4L,1O4M,1O4N,1O4O,1O4P,1O4Q,1O4R,1SHA,1SHB,1SHD,1SPR,1SPS,1Y57,1YI6,2BDF,2BDJ,2H8H,2PTK,2SRC,4MXO,4MXX,4OML,4OMO,5OB0,5OB1,6ATE,6E6E,7A34,7A35,7A36,7A37,7A3D,7PVY,7PVZ Proto-oncogene tyrosine-protein kinase Src SRC_HUMAN P12931 E1P5V4 Q76P87 Q86VB9 Q9H5A8 784784 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(OC)cc4OC)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C46H50N8O8/c1-8-30-25-31(43(55)47-19-20-60-23-24-61-22-21-57-5)27-32(26-30)49-44-48-18-17-42(52-44)62-38-16-14-36(34-11-9-10-12-35(34)38)50-45(56)51-41-29-40(46(2,3)4)53-54(41)37-15-13-33(58-6)28-39(37)59-7/h1,9-18,25-29H,19-24H2,2-7H3,(H,47,55)(H,48,49,52)(H2,50,51,56) MQJCGMXEGJYQKF-UHFFFAOYSA-N 392702 3-((4-((4-(3-(3-(tert-Butyl)-1-(2,4-dimethoxyphenyl)-1H-pyrazol-5-yl)ureido)naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-5-ethynyl-N-(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-benzamide::US10301288, Example 13 Tyrosine-protein kinase SYK Homo sapiens 123 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=763&target=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392702&enzyme=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search 86304818 404961027 1 MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 1XBA,1XBB,1XBC,3FQE,3FQH,3FQS,3SRV,3TUB,3TUC,3TUD,3VF8,3VF9,4DFL,4DFN,4F4P,4FL1,4FL2,4FYN,4FYO,4FZ6,4FZ7,4GFG,4I0R,4I0S,4I0T,4PUZ,4PV0,4RSS,4WNM,4XG2,4XG3,4XG4,4XG6,4XG7,4XG8,4XG9,4YJO,4YJP,4YJQ,4YJR,4YJS,4YJT,4YJU,4YJV,5C26,5C27,5GHV,5LMA,5LMB,5T68,5TIU,5TR6,5TT7,5Y5T,5Y5U,6HM6,6HM7,6SSB,6VOV,6ZC0,6ZCP,6ZCQ,6ZCR,6ZCS,6ZCU,6ZCX,6ZCY,7SA7,8BI2 Tyrosine-protein kinase SYK KSYK_HUMAN P43405 784785 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(OC)cc4OC)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C46H50N8O8/c1-8-30-25-31(43(55)47-19-20-60-23-24-61-22-21-57-5)27-32(26-30)49-44-48-18-17-42(52-44)62-38-16-14-36(34-11-9-10-12-35(34)38)50-45(56)51-41-29-40(46(2,3)4)53-54(41)37-15-13-33(58-6)28-39(37)59-7/h1,9-18,25-29H,19-24H2,2-7H3,(H,47,55)(H,48,49,52)(H2,50,51,56) MQJCGMXEGJYQKF-UHFFFAOYSA-N 392702 3-((4-((4-(3-(3-(tert-Butyl)-1-(2,4-dimethoxyphenyl)-1H-pyrazol-5-yl)ureido)naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-5-ethynyl-N-(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-benzamide::US10301288, Example 13 Glycogen synthase kinase-3 alpha Homo sapiens 2129 US Patent 10.7270/Q24B33N6 aid1798903 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392702&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 86304818 404961027 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 784786 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C47H53N8O7P/c1-8-32-26-34(44(56)48-20-21-60-24-25-61-23-22-59-5)29-35(27-32)50-45-49-19-18-43(53-45)62-40-17-16-39(37-14-9-10-15-38(37)40)51-46(57)52-42-30-41(47(2,3)4)54-55(42)36-13-11-12-33(28-36)31-63(6,7)58/h1,9-19,26-30H,20-25,31H2,2-7H3,(H,48,56)(H,49,50,53)(H2,51,52,57) RHCMQQAUBJPPPW-UHFFFAOYSA-N 392703 3-((4-((4-(3-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl)phenyl)-1H-pyrazol-5-yl)-ureido)naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-5-ethynyl-N-(2-(2-(2-methoxyethoxy)-ethoxy)ethyl)benzamide::US10301288, Example 14 Mitogen-activated protein kinase 14 Homo sapiens 88.0 US Patent 10.7270/Q24B33N6 aid1798901 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392703 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392703&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 86304649 404961028 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 784787 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C47H53N8O7P/c1-8-32-26-34(44(56)48-20-21-60-24-25-61-23-22-59-5)29-35(27-32)50-45-49-19-18-43(53-45)62-40-17-16-39(37-14-9-10-15-38(37)40)51-46(57)52-42-30-41(47(2,3)4)54-55(42)36-13-11-12-33(28-36)31-63(6,7)58/h1,9-19,26-30H,20-25,31H2,2-7H3,(H,48,56)(H,49,50,53)(H2,51,52,57) RHCMQQAUBJPPPW-UHFFFAOYSA-N 392703 3-((4-((4-(3-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl)phenyl)-1H-pyrazol-5-yl)-ureido)naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-5-ethynyl-N-(2-(2-(2-methoxyethoxy)-ethoxy)ethyl)benzamide::US10301288, Example 14 Proto-oncogene tyrosine-protein kinase Src Human 4.00 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392703 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=13&target=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392703&enzyme=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search 86304649 404961028 1 MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 1FMK,1HCS,1HCT,1O41,1O42,1O43,1O44,1O45,1O46,1O47,1O48,1O49,1O4A,1O4B,1O4C,1O4D,1O4E,1O4F,1O4G,1O4H,1O4I,1O4J,1O4K,1O4L,1O4M,1O4N,1O4O,1O4P,1O4Q,1O4R,1SHA,1SHB,1SHD,1SPR,1SPS,1Y57,1YI6,2BDF,2BDJ,2H8H,2PTK,2SRC,4MXO,4MXX,4OML,4OMO,5OB0,5OB1,6ATE,6E6E,7A34,7A35,7A36,7A37,7A3D,7PVY,7PVZ Proto-oncogene tyrosine-protein kinase Src SRC_HUMAN P12931 E1P5V4 Q76P87 Q86VB9 Q9H5A8 784788 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C47H53N8O7P/c1-8-32-26-34(44(56)48-20-21-60-24-25-61-23-22-59-5)29-35(27-32)50-45-49-19-18-43(53-45)62-40-17-16-39(37-14-9-10-15-38(37)40)51-46(57)52-42-30-41(47(2,3)4)54-55(42)36-13-11-12-33(28-36)31-63(6,7)58/h1,9-19,26-30H,20-25,31H2,2-7H3,(H,48,56)(H,49,50,53)(H2,51,52,57) RHCMQQAUBJPPPW-UHFFFAOYSA-N 392703 3-((4-((4-(3-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl)phenyl)-1H-pyrazol-5-yl)-ureido)naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-5-ethynyl-N-(2-(2-(2-methoxyethoxy)-ethoxy)ethyl)benzamide::US10301288, Example 14 Tyrosine-protein kinase SYK Homo sapiens 20.0 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392703 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=763&target=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392703&enzyme=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search 86304649 404961028 1 MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 1XBA,1XBB,1XBC,3FQE,3FQH,3FQS,3SRV,3TUB,3TUC,3TUD,3VF8,3VF9,4DFL,4DFN,4F4P,4FL1,4FL2,4FYN,4FYO,4FZ6,4FZ7,4GFG,4I0R,4I0S,4I0T,4PUZ,4PV0,4RSS,4WNM,4XG2,4XG3,4XG4,4XG6,4XG7,4XG8,4XG9,4YJO,4YJP,4YJQ,4YJR,4YJS,4YJT,4YJU,4YJV,5C26,5C27,5GHV,5LMA,5LMB,5T68,5TIU,5TR6,5TT7,5Y5T,5Y5U,6HM6,6HM7,6SSB,6VOV,6ZC0,6ZCP,6ZCQ,6ZCR,6ZCS,6ZCU,6ZCX,6ZCY,7SA7,8BI2 Tyrosine-protein kinase SYK KSYK_HUMAN P43405 784789 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C47H53N8O7P/c1-8-32-26-34(44(56)48-20-21-60-24-25-61-23-22-59-5)29-35(27-32)50-45-49-19-18-43(53-45)62-40-17-16-39(37-14-9-10-15-38(37)40)51-46(57)52-42-30-41(47(2,3)4)54-55(42)36-13-11-12-33(28-36)31-63(6,7)58/h1,9-19,26-30H,20-25,31H2,2-7H3,(H,48,56)(H,49,50,53)(H2,51,52,57) RHCMQQAUBJPPPW-UHFFFAOYSA-N 392703 3-((4-((4-(3-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl)phenyl)-1H-pyrazol-5-yl)-ureido)naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-5-ethynyl-N-(2-(2-(2-methoxyethoxy)-ethoxy)ethyl)benzamide::US10301288, Example 14 Glycogen synthase kinase-3 alpha Homo sapiens 402 US Patent 10.7270/Q24B33N6 aid1798903 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392703 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392703&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 86304649 404961028 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 784790 COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)(C)C)c4ccccc34)ccn2)cc(OC)c1 InChI=1S/C47H56N7O8P/c1-47(2,3)42-30-44(54(53-42)35-12-10-11-32(25-35)31-63(6,7)57)52-46(56)51-40-15-16-41(39-14-9-8-13-38(39)40)62-36-17-18-48-43(29-36)50-34-26-33(27-37(28-34)59-5)45(55)49-19-20-60-23-24-61-22-21-58-4/h8-18,25-30H,19-24,31H2,1-7H3,(H,48,50)(H,49,55)(H2,51,52,56) RPHZNUQELARGGG-UHFFFAOYSA-N 392704 3-((4-((4-(3-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl)phenyl)-1H-pyrazol-5-yl)-ureido)naphthalen-1-yl)oxy)pyridin-2-yl)amino)-5-methoxy-N-(2-(2-(2-methoxyethoxy)-ethoxy)ethyl)benzamide::US10301288, Example 15 Mitogen-activated protein kinase 14 Homo sapiens 34.0 US Patent 10.7270/Q24B33N6 aid1798901 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3881&target=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392704&enzyme=Mitogen-activated+protein+kinase+14&column=ki&startPg=0&Increment=50&submit=Search 86304819 404961029 1 MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES 1DI9,1IAN,1KV1,1KV2,1M7Q,1OUK,1OUY,1OZ1,1R39,1W7H,1W82,1W83,1W84,1WBN,1WBO,1WBS,1WBT,1WBV,1WBW,1WFC,1YQJ,1ZYJ,1ZZ2,1ZZL,2BAJ,2BAK,2BAL,2EWA,2GFS,2LGC,2NPQ,2OKR,2ONL,2QD9,2RG5,2RG6,2YIS,2YIW,2YIX,2ZAZ,2ZB0,2ZB1,3BV2,3BV3,3BX5,3C5U,3D7Z,3D83,3DS6,3DT1,3E92,3E93,3FC1,3FKL,3FKN,3FL4,3FLQ,3FLS,3FLW,3FLY,3FLZ,3FMH,3FMJ,3FMK,3FML,3FMM,3FMN,3FSF,3FSK,3GCU,3GFE,3HA8,3HEC,3HEG,3HL7,3HLL,3HP2,3HP5,3HRB,3HUC,3HV4,3HV5,3HV6,3HV7,3HVC,3IPH,3ITZ,3K3I,3K3J,3KF7,3KQ7,3L8X,3LFA,3LHJ,3MGY,3MPT,3MVL,3MVM,3MW1,3NNU,3NNV,3NNW,3NNX,3NWW,3OCG,3QUD,3QUE,3RIN,3ROC,3S3I,3S4Q,3U8W,3UVP,3UVQ,3UVR,3ZS5,3ZSG,3ZSH,3ZSI,3ZYA,4A9Y,4AA0,4AA4,4AA5,4AAC,4DLI,4DLJ,4E5B,4E6A,4E6C,4E8A,4EH2,4EH3,4EH4,4EH5,4EH6,4EH7,4EH8,4EH9,4EHV,4EWQ,4F9W,4F9Y,4FA2,4KIN,4KIP,4KIQ,4L8M,4R3C,4ZTH,5ETA,5ETC,5ML5,5MTX,5MTY,5N63,5N64,5N65,5N66,5N67,5N68,5OMG,5OMH,5TBE,5TCO,5XYX,5XYY,6HWT,6HWU,6HWV,6QDZ,6QE1,6QYX,6TCA,6ZQS Mitogen-activated protein kinase 14 MK14_HUMAN Q16539 A6ZJ92 A8K6P4 B0LPH0 B5TY32 O60776 Q13083 Q14084 Q8TDX0 784791 COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)(C)C)c4ccccc34)ccn2)cc(OC)c1 InChI=1S/C47H56N7O8P/c1-47(2,3)42-30-44(54(53-42)35-12-10-11-32(25-35)31-63(6,7)57)52-46(56)51-40-15-16-41(39-14-9-8-13-38(39)40)62-36-17-18-48-43(29-36)50-34-26-33(27-37(28-34)59-5)45(55)49-19-20-60-23-24-61-22-21-58-4/h8-18,25-30H,19-24,31H2,1-7H3,(H,48,50)(H,49,55)(H2,51,52,56) RPHZNUQELARGGG-UHFFFAOYSA-N 392704 3-((4-((4-(3-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl)phenyl)-1H-pyrazol-5-yl)-ureido)naphthalen-1-yl)oxy)pyridin-2-yl)amino)-5-methoxy-N-(2-(2-(2-methoxyethoxy)-ethoxy)ethyl)benzamide::US10301288, Example 15 Proto-oncogene tyrosine-protein kinase Src Human 18.0 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=13&target=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392704&enzyme=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search 86304819 404961029 1 MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 1FMK,1HCS,1HCT,1O41,1O42,1O43,1O44,1O45,1O46,1O47,1O48,1O49,1O4A,1O4B,1O4C,1O4D,1O4E,1O4F,1O4G,1O4H,1O4I,1O4J,1O4K,1O4L,1O4M,1O4N,1O4O,1O4P,1O4Q,1O4R,1SHA,1SHB,1SHD,1SPR,1SPS,1Y57,1YI6,2BDF,2BDJ,2H8H,2PTK,2SRC,4MXO,4MXX,4OML,4OMO,5OB0,5OB1,6ATE,6E6E,7A34,7A35,7A36,7A37,7A3D,7PVY,7PVZ Proto-oncogene tyrosine-protein kinase Src SRC_HUMAN P12931 E1P5V4 Q76P87 Q86VB9 Q9H5A8 784792 COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)(C)C)c4ccccc34)ccn2)cc(OC)c1 InChI=1S/C47H56N7O8P/c1-47(2,3)42-30-44(54(53-42)35-12-10-11-32(25-35)31-63(6,7)57)52-46(56)51-40-15-16-41(39-14-9-8-13-38(39)40)62-36-17-18-48-43(29-36)50-34-26-33(27-37(28-34)59-5)45(55)49-19-20-60-23-24-61-22-21-58-4/h8-18,25-30H,19-24,31H2,1-7H3,(H,48,50)(H,49,55)(H2,51,52,56) RPHZNUQELARGGG-UHFFFAOYSA-N 392704 3-((4-((4-(3-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl)phenyl)-1H-pyrazol-5-yl)-ureido)naphthalen-1-yl)oxy)pyridin-2-yl)amino)-5-methoxy-N-(2-(2-(2-methoxyethoxy)-ethoxy)ethyl)benzamide::US10301288, Example 15 Tyrosine-protein kinase SYK Homo sapiens 57.0 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=763&target=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392704&enzyme=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search 86304819 404961029 1 MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 1XBA,1XBB,1XBC,3FQE,3FQH,3FQS,3SRV,3TUB,3TUC,3TUD,3VF8,3VF9,4DFL,4DFN,4F4P,4FL1,4FL2,4FYN,4FYO,4FZ6,4FZ7,4GFG,4I0R,4I0S,4I0T,4PUZ,4PV0,4RSS,4WNM,4XG2,4XG3,4XG4,4XG6,4XG7,4XG8,4XG9,4YJO,4YJP,4YJQ,4YJR,4YJS,4YJT,4YJU,4YJV,5C26,5C27,5GHV,5LMA,5LMB,5T68,5TIU,5TR6,5TT7,5Y5T,5Y5U,6HM6,6HM7,6SSB,6VOV,6ZC0,6ZCP,6ZCQ,6ZCR,6ZCS,6ZCU,6ZCX,6ZCY,7SA7,8BI2 Tyrosine-protein kinase SYK KSYK_HUMAN P43405 784793 COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(nn4-c4cccc(CP(C)(C)=O)c4)C(C)(C)C)c4ccccc34)ccn2)cc(OC)c1 InChI=1S/C47H56N7O8P/c1-47(2,3)42-30-44(54(53-42)35-12-10-11-32(25-35)31-63(6,7)57)52-46(56)51-40-15-16-41(39-14-9-8-13-38(39)40)62-36-17-18-48-43(29-36)50-34-26-33(27-37(28-34)59-5)45(55)49-19-20-60-23-24-61-22-21-58-4/h8-18,25-30H,19-24,31H2,1-7H3,(H,48,50)(H,49,55)(H2,51,52,56) RPHZNUQELARGGG-UHFFFAOYSA-N 392704 3-((4-((4-(3-(3-(tert-Butyl)-1-(3-((dimethylphosphoryl)methyl)phenyl)-1H-pyrazol-5-yl)-ureido)naphthalen-1-yl)oxy)pyridin-2-yl)amino)-5-methoxy-N-(2-(2-(2-methoxyethoxy)-ethoxy)ethyl)benzamide::US10301288, Example 15 Glycogen synthase kinase-3 alpha Homo sapiens 3196 US Patent 10.7270/Q24B33N6 aid1798903 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392704&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 86304819 404961029 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 784794 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(cc4)N(C)C)C(C)(C)C)c4ccccc34)n2)cc(OC)c1 InChI=1S/C45H53N9O7/c1-45(2,3)39-29-40(54(52-39)33-14-12-32(13-15-33)53(4)5)50-44(56)49-37-16-17-38(36-11-9-8-10-35(36)37)61-41-18-19-47-43(51-41)48-31-26-30(27-34(28-31)58-7)42(55)46-20-21-59-24-25-60-23-22-57-6/h8-19,26-29H,20-25H2,1-7H3,(H,46,55)(H,47,48,51)(H2,49,50,56) JTZCPHYRKRLLIF-UHFFFAOYSA-N 392705 3-((4-((4-(3-(3-(tert-Butyl)-1-(4-(dimethylamino)phenyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-5-methoxy-N-(2-(2-(2-methoxyethoxy)-ethoxy)ethyl)benzamide::US10301288, Example 16 Proto-oncogene tyrosine-protein kinase Src Human 15.0 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392705 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=13&target=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392705&enzyme=Proto-oncogene+tyrosine-protein+kinase+Src&column=ki&startPg=0&Increment=50&submit=Search 86304989 404961030 1 MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 1FMK,1HCS,1HCT,1O41,1O42,1O43,1O44,1O45,1O46,1O47,1O48,1O49,1O4A,1O4B,1O4C,1O4D,1O4E,1O4F,1O4G,1O4H,1O4I,1O4J,1O4K,1O4L,1O4M,1O4N,1O4O,1O4P,1O4Q,1O4R,1SHA,1SHB,1SHD,1SPR,1SPS,1Y57,1YI6,2BDF,2BDJ,2H8H,2PTK,2SRC,4MXO,4MXX,4OML,4OMO,5OB0,5OB1,6ATE,6E6E,7A34,7A35,7A36,7A37,7A3D,7PVY,7PVZ Proto-oncogene tyrosine-protein kinase Src SRC_HUMAN P12931 E1P5V4 Q76P87 Q86VB9 Q9H5A8 784795 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(cc4)N(C)C)C(C)(C)C)c4ccccc34)n2)cc(OC)c1 InChI=1S/C45H53N9O7/c1-45(2,3)39-29-40(54(52-39)33-14-12-32(13-15-33)53(4)5)50-44(56)49-37-16-17-38(36-11-9-8-10-35(36)37)61-41-18-19-47-43(51-41)48-31-26-30(27-34(28-31)58-7)42(55)46-20-21-59-24-25-60-23-22-57-6/h8-19,26-29H,20-25H2,1-7H3,(H,46,55)(H,47,48,51)(H2,49,50,56) JTZCPHYRKRLLIF-UHFFFAOYSA-N 392705 3-((4-((4-(3-(3-(tert-Butyl)-1-(4-(dimethylamino)phenyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-5-methoxy-N-(2-(2-(2-methoxyethoxy)-ethoxy)ethyl)benzamide::US10301288, Example 16 Tyrosine-protein kinase SYK Homo sapiens 27.0 US Patent 10.7270/Q24B33N6 aid1798902 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392705 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=763&target=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392705&enzyme=Tyrosine-protein+kinase+SYK&column=ki&startPg=0&Increment=50&submit=Search 86304989 404961030 1 MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 1XBA,1XBB,1XBC,3FQE,3FQH,3FQS,3SRV,3TUB,3TUC,3TUD,3VF8,3VF9,4DFL,4DFN,4F4P,4FL1,4FL2,4FYN,4FYO,4FZ6,4FZ7,4GFG,4I0R,4I0S,4I0T,4PUZ,4PV0,4RSS,4WNM,4XG2,4XG3,4XG4,4XG6,4XG7,4XG8,4XG9,4YJO,4YJP,4YJQ,4YJR,4YJS,4YJT,4YJU,4YJV,5C26,5C27,5GHV,5LMA,5LMB,5T68,5TIU,5TR6,5TT7,5Y5T,5Y5U,6HM6,6HM7,6SSB,6VOV,6ZC0,6ZCP,6ZCQ,6ZCR,6ZCS,6ZCU,6ZCX,6ZCY,7SA7,8BI2 Tyrosine-protein kinase SYK KSYK_HUMAN P43405 784796 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(cc4)N(C)C)C(C)(C)C)c4ccccc34)n2)cc(OC)c1 InChI=1S/C45H53N9O7/c1-45(2,3)39-29-40(54(52-39)33-14-12-32(13-15-33)53(4)5)50-44(56)49-37-16-17-38(36-11-9-8-10-35(36)37)61-41-18-19-47-43(51-41)48-31-26-30(27-34(28-31)58-7)42(55)46-20-21-59-24-25-60-23-22-57-6/h8-19,26-29H,20-25H2,1-7H3,(H,46,55)(H,47,48,51)(H2,49,50,56) JTZCPHYRKRLLIF-UHFFFAOYSA-N 392705 3-((4-((4-(3-(3-(tert-Butyl)-1-(4-(dimethylamino)phenyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-5-methoxy-N-(2-(2-(2-methoxyethoxy)-ethoxy)ethyl)benzamide::US10301288, Example 16 Glycogen synthase kinase-3 alpha Homo sapiens 646 US Patent 10.7270/Q24B33N6 aid1798903 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392705 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392705&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 86304989 404961030 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959 784797 COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(nn4-c4ccc(OC)cc4C)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C InChI=1S/C46H50N8O7/c1-8-31-26-32(43(55)47-19-20-59-23-24-60-22-21-57-6)28-33(27-31)49-44-48-18-17-42(52-44)61-39-16-14-37(35-11-9-10-12-36(35)39)50-45(56)51-41-29-40(46(3,4)5)53-54(41)38-15-13-34(58-7)25-30(38)2/h1,9-18,25-29H,19-24H2,2-7H3,(H,47,55)(H,48,49,52)(H2,50,51,56) NZZZTABIHCIBAE-UHFFFAOYSA-N 392706 3-((4-((4-(3-(3-(tert-Butyl)-1-(4-methoxy-2-methylphenyl)-1H-pyrazol-5-yl)ureido)-naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-5-ethynyl-N-(2-(2-(2-methoxyethoxy)-ethoxy)ethyl)benzamide::US10301288, Example 17 Glycogen synthase kinase-3 alpha Homo sapiens 12093 US Patent 10.7270/Q24B33N6 aid1798903 US10301288 Fyfe, MC 5/28/2019 3/26/2020 Topivert Pharma Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=392706 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1017&target=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=392706&enzyme=Glycogen+synthase+kinase-3+alpha&column=ki&startPg=0&Increment=50&submit=Search 86304990 404961031 1 MSGGGPSGGGPGGSGRARTSSFAEPGGGGGGGGGGPGGSASGPGGTGGGKASVGAMGGGVGASSSGGGPGGSGGGGSGGPGAGTSFPPPGVKLGRDSGKVTTVVATLGQGPERSQEVAYTDIKVIGNGSFGVVYQARLAETRELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDELYLNLVLEYVPETVYRVARHFTKAKLTIPILYVKVYMYQLFRSLAYIHSQGVCHRDIKPQNLLVDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFKSRTPPEAIALCSSLLEYTPSSRLSPLEACAHSFFDELRCLGTQLPNNRPLPPLFNFSAGELSIQPSLNAILIPPHLRSPAGTTTLTPSSQALTETPTSSDWQSTDATPTLTNSS 7B6F,7SXF,7SXG,7Z1F,7Z1G,8AUZ,8AV1 Glycogen synthase kinase-3 alpha GSK3A_HUMAN P49840 O14959